Cargando…
Delayed Infliximab Treatment Affects the Outcomes of Patients With Crohn's Disease During the COVID-19 Epidemic in China: A Propensity Score-Matched Analysis
Background: The coronavirus disease 2019 (COVID-19) has swept the world and led to delays in the treatment of Crohn's disease patients treated with biologics. This study aims to investigate the risk factors for delayed treatment during the epidemic and to observe the short- and long-term influe...
Autores principales: | Li, Yong, Chen, Lulu, Chen, Shuijiao, Liu, Xiaowei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790060/ https://www.ncbi.nlm.nih.gov/pubmed/35096910 http://dx.doi.org/10.3389/fmed.2021.819557 |
Ejemplares similares
-
Adalimumab vs Infliximab in Pediatric Patients With Crohn's Disease: A Propensity Score Analysis and Predictors of Treatment Escalation
por: Bronsky, Jiri, et al.
Publicado: (2022) -
Brain Abscesses in Crohn’s Disease as a Complication of Infliximab Therapy
por: Mansour, Mahmoud M, et al.
Publicado: (2021) -
Blood Eosinophils and Clinical Outcomes in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Propensity Score Matching Analysis of Real-World Data in China
por: Cui, Yanan, et al.
Publicado: (2021) -
Association between endocrine therapy and cognitive decline in breast cancer based on propensity score matching
por: Yin, Yulian, et al.
Publicado: (2023) -
Hirschsprung disease in an adult masquerading as stricturing Crohn’s disease: a missed rare co-morbidity
por: Chen, Yiqian, et al.
Publicado: (2023)